News

Excellent third quarter for Valeant

Quebec-based Valeant Pharmaceuticals, owner of Bausch + Lomb, among others, recorded its second best quarterly results since it was founded in 1960.

Read More

Allergan CEO honoured

Allergan CEO David Pyott was ranked the fourth best-performing CEO in the world by Harvard Business Review.

Read More

Tough quarter for Johnson & Johnson in the eye care market

Despite a good quarter for the company in general (sales of US$18.5 billion, up by 5.1% over last year), Johnson & Johnson reported a drop in eye care product sales in the third quarter of 2014.

Read More

Valeant increases offer for Allergan

Quebec-based Valeant Pharmaceuticals has increased its takeover bid for Allergan from US$50 to nearly US$60 billion.

Read More

A strong quarter for Essilor

Essilor’s revenue rose to CA$1.59 million in the third quarter of 2014, a 14.5% increase over the same period last year.

Read More

FLEYE wins Good Design Award 2014

The Danish company FLEYE wins the Good Design Award 2014, the most prestigious award for design in Japan.

Read More

EyeCheck shortlisted for prestigious James Dyson award

EyeCheck, a start-up founded by University of Waterloo students, made the final list of 20 entries for the James Dyson Award.

Read More

A first in Canada: two patients receive the Argus II implant

Two patients at the Toronto Western Hospital have become the first in Canada to receive the Argus II Retinal Prosthesis Device.

Read More

New sports vision clinic at the University of Waterloo

The School of Optometry & Vision Science now has a clinic to promote sports vision research.

Read More

Improved access to eye care for Saskatchewan diabetics

In Saskatchewan, the government is now fully covering the cost of annual eye examinations for diabetic adults This measure is the result of an...

Read More